GlaxoSmithKline provided details on its strategy and growth prospects. Over the next 5 years, GSK expects to deliver sales and operating profit growth of more than 5% and more than 10%, respectively. By 2031, the company plans to sell more than Β£33 billion worth of products. GSK estimates that certain assets together could generate annual sales of more than Β£20 billion.
GlaxoSmithKline provided details on its strategy and growth prospects. Over the next 5 years, GSK expects to deliver sales and operating profit growth of more than 5% and more than 10%, respectively. By 2031, the company plans to sell more than Β£33 billion worth of products. GSK estimates that certain assets together could generate annual sales of more than Β£20 billion. 
gsk.com
English (US) 